Johnson & johnson, the lagrest health-care products manufacturer, continued to sell a vaginal mesh implant many months after The Food and Drug Administration told the company to halt their sales. In an August 24, 2007 letter the FDA cited the potential high rusk for organ perforation when surgeons insert the mesh vaginally to support weakened pelvic tissue. An agency report in July found a five-fold jump in deaths injuries or malfunctions tied to prolapse mesh inserted vaginally. In June of this uear, J&J said it would stop selling four vaginal mesh implants but did not recall the products. The company faces about 1,400 lawsuits by women who say the mesh caused organ perforation, pain, scarring and nerve damage.